Manzo Pharmaceuticals, Inc.
MNZO
Rank in Stocks
#32915
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the... Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
Share Price
$0.0002
Last synced: 2026-11-12
Market Cap
$1,000.00K
Change (1 day)
0.00%
Change (1 year)
100.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Manzo Pharmaceuticals, Inc. (MNZO)
Category
Healthcare
EPS for Manzo Pharmaceuticals, Inc. (MNZO)
EPS as of March 2026 TTM: 0.00
According to Manzo Pharmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is 0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2015 EPS of 0.00.
EPS history for Manzo Pharmaceuticals, Inc. from 2003 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2015 | 0.00 | -100.00% |
| 2014 | 0.00 | -99.76% |
| 2004 | $-1.20 | 0.00% |
| 2003 | $-1.20 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | - |
DE
|
|
| $6.01 | - |
DE
|
|
| $1.53 | - |
JP
|
|
| $3.66 | - |
CH
|
|
| $0.45 | - |
IL
|
Questions about Manzo Pharmaceuticals, Inc.'s earnings per share (EPS)
What was Manzo Pharmaceuticals, Inc.'s earnings per share (EPS) in 2025?
In 2025, Manzo Pharmaceuticals, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2015.
How does Manzo Pharmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
Manzo Pharmaceuticals, Inc.'s earnings per share (EPS) (0.00) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.